We are live on
!
Find out more
NCM
Novare Capital Management Portfolio holdings
AUM
$1.26B
1-Year Est. Return
20.28%
This Fund
S&P 500
This Quarter
Est. Return
-12.6%
1 Year Est. Return
+20.28%
3 Year Est. Return
+65.67%
5 Year Est. Return
+78.77%
10 Year Est. Return
+251.06%
AUM
$810M
AUM Growth
-$128M
(-14%)
Cap. Flow
+$1.04M
Cap. Flow
% of AUM
0.13%
Top 10 Holdings %
Top 10 Hldgs %
28.71%
Holding
186
New
11
Increased
72
Reduced
59
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thor Industries
THO
|
+$7.65M |
| 2 |
Realty Income
O
|
+$5.91M |
| 3 |
Duke Energy
DUK
|
+$5.12M |
| 4 |
Merck
MRK
|
+$4.89M |
| 5 |
Vanguard Information Technology ETF
VGT
|
+$4.66M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$7.75M |
| 2 |
iShares Fallen Angels USD Bond ETF
FALN
|
+$7.2M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$5.79M |
| 4 |
PayPal
PYPL
|
+$3.8M |
| 5 |
American Tower
AMT
|
+$3.69M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 12.09% |
| 3 | Consumer Discretionary | 9.62% |
| 4 | Industrials | 8.63% |
| 5 | Financials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
State Street SPDR S&P 500 ETF Trust
SPY
$781B
| $45.4M | 5.6% |
120,290
+787
| +0.7% | +$322K |
|
2
Microsoft
MSFT
$2.89T
| $34.6M | 4.26% |
134,540
+1,749
| +1% | +$475K |
|
3
Apple
AAPL
$4.95T
| $28.7M | 3.54% |
209,768
-3,015
| -1% | -$457K |
|
4
Johnson & Johnson
JNJ
$641B
| $21.3M | 2.63% |
119,855
+526
| +0.4% | +$93.7K |
|
5
UnitedHealth
UNH
$379B
| $21.1M | 2.61% |
41,144
-1,407
| -3% | -$707K |
|
6
iShares Core S&P 500 ETF
IVV
$869B
| $17.8M | 2.2% |
46,952
+10,980
| +31% | +$4.52M |
|
7
Alphabet (Google) Class A
GOOGL
$3.99T
| $17.5M | 2.16% |
160,720
+15,640
| +11% | +$1.84M |
|
|
BSCP
8
DELISTED
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
| $16.4M | 2.03% |
803,873
+111,325
| +16% | +$2.29M |
|
9
Walmart Inc
WMT
$889B
| $15.2M | 1.87% |
374,328
-234
| -0.1% | -$10.8K |
|
|
10
Merck
MRK
$323B
| $14.7M | 1.82% |
161,749
+55,123
| +52% | +$4.89M |
|
11
Berkshire Hathaway Class B
BRK.B
$1.07T
| $14.3M | 1.76% |
52,300
-393
| -0.7% | -$123K |
|
12
Comcast
CMCSA
$80.9B
| $13.8M | 1.7% |
350,473
+16,993
| +5% | +$729K |
|
13
Amazon
AMZN
$2.49T
| $13.7M | 1.69% |
129,272
+492
| +0.4% | +$61.6K |
|
14
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
| $13.6M | 1.68% |
178,939
-5,146
| -3% | -$395K |
|
|
15
Realty Income
O
$61.1B
| $12.5M | 1.54% |
182,906
+86,051
| +89% | +$5.91M |
|
16
JPMorgan Chase
JPM
$947B
| $11.5M | 1.42% |
101,955
-571
| -0.6% | -$70.7K |
|
17
Texas Instruments
TXN
$255B
| $11.3M | 1.4% |
73,795
+1,946
| +3% | +$327K |
|
18
Thermo Fisher Scientific
TMO
$208B
| $11.2M | 1.38% |
20,589
-383
| -2% | -$211K |
|
19
Bank of America
BAC
$436B
| $11.2M | 1.38% |
359,269
+10,369
| +3% | +$373K |
|
20
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$14.9B
| $10.6M | 1.31% |
141,278
+5,305
| +4% | +$431K |
|
21
Invesco BulletShares 2027 Corporate Bond ETF
BSCR
$4.58B
| $10.6M | 1.3% |
544,751
+27,007
| +5% | +$529K |
|
22
Broadcom
AVGO
$1.82T
| $10.5M | 1.3% |
216,600
-5,360
| -2% | -$301K |
|
23
RTX Corp
RTX
$294B
| $10.5M | 1.29% |
108,977
-2,253
| -2% | -$217K |
|
24
Abbott
ABT
$182B
| $10.2M | 1.25% |
93,430
+883
| +1% | +$100K |
|
25
Honeywell
HON
$77.9B
| $9.41M | 1.16% |
57,457
-9,809
| -15% | -$1.76M |
|
Similar funds
TWP
TBC
TC
HP
DAM
PIA
DP
TCA
Novare Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Novare Capital Management held 186 positions worth $810M, down 14% from $938M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Novare Capital Management's Q2 2022 filing shows 11 new, 72 increased, 59 reduced and 23 closed positions. Its largest new stake was Thor Industries: 98,575 shares worth $7.37M. The largest sale was Bristol-Myers Squibb, an estimated $7.75M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Novare Capital Management's largest Q2 2022 buy was Thor Industries: 98,575 shares worth $7.37M.
- Novare Capital Management added most to Realty Income in Q2 2022, an estimated $5.91M increase.
- Novare Capital Management's biggest Q2 2022 reduction was Bristol-Myers Squibb, cutting an estimated $7.75M.
- Novare Capital Management fully exited Medtronic in Q2 2022, selling an estimated $1.28M.
- Novare Capital Management's ten largest holdings make up 29% of its $810M portfolio in Q2 2022.
- Novare Capital Management opened 11 new positions and closed 23 in Q2 2022.
- Novare Capital Management's portfolio value fell 14% quarter-over-quarter to $810M.
Based on Novare Capital Management's 13F filing for Q2 2022, filed 3 Aug 2022.